Diabetics in hemodialysis: Glycemic control by open-loop devices

D. Spotti, G. Slaviero, E. La Rocca, R. Quartagno, M. Melandri, G. Pozza

Research output: Contribution to journalArticle

Abstract

The blood-sugar level in insulin-dependent diabetic patients with end-stage renal disease (ESRD) during hemodialysis treatment is difficult to control. Use of an open-loop device for continuous subcutaneous insulin delivery is preferred in the treatment of uremic diabetics to obtain acceptable glycemic control. We reported our experience of achieving better metabolic control using the micropump instead of intensive conventional insulin administration in diabetic hemodialysis patients.

Original languageEnglish
Pages (from-to)417-418+425
JournalDialysis and Transplantation
Volume17
Issue number8
Publication statusPublished - 1988

Fingerprint

Renal Dialysis
Insulin
Equipment and Supplies
Chronic Kidney Failure
Blood Glucose
Therapeutics

ASJC Scopus subject areas

  • Nephrology
  • Transplantation

Cite this

Spotti, D., Slaviero, G., La Rocca, E., Quartagno, R., Melandri, M., & Pozza, G. (1988). Diabetics in hemodialysis: Glycemic control by open-loop devices. Dialysis and Transplantation, 17(8), 417-418+425.

Diabetics in hemodialysis : Glycemic control by open-loop devices. / Spotti, D.; Slaviero, G.; La Rocca, E.; Quartagno, R.; Melandri, M.; Pozza, G.

In: Dialysis and Transplantation, Vol. 17, No. 8, 1988, p. 417-418+425.

Research output: Contribution to journalArticle

Spotti, D, Slaviero, G, La Rocca, E, Quartagno, R, Melandri, M & Pozza, G 1988, 'Diabetics in hemodialysis: Glycemic control by open-loop devices', Dialysis and Transplantation, vol. 17, no. 8, pp. 417-418+425.
Spotti D, Slaviero G, La Rocca E, Quartagno R, Melandri M, Pozza G. Diabetics in hemodialysis: Glycemic control by open-loop devices. Dialysis and Transplantation. 1988;17(8):417-418+425.
Spotti, D. ; Slaviero, G. ; La Rocca, E. ; Quartagno, R. ; Melandri, M. ; Pozza, G. / Diabetics in hemodialysis : Glycemic control by open-loop devices. In: Dialysis and Transplantation. 1988 ; Vol. 17, No. 8. pp. 417-418+425.
@article{270f535b61464720a3d75d4dfc9533ff,
title = "Diabetics in hemodialysis: Glycemic control by open-loop devices",
abstract = "The blood-sugar level in insulin-dependent diabetic patients with end-stage renal disease (ESRD) during hemodialysis treatment is difficult to control. Use of an open-loop device for continuous subcutaneous insulin delivery is preferred in the treatment of uremic diabetics to obtain acceptable glycemic control. We reported our experience of achieving better metabolic control using the micropump instead of intensive conventional insulin administration in diabetic hemodialysis patients.",
author = "D. Spotti and G. Slaviero and {La Rocca}, E. and R. Quartagno and M. Melandri and G. Pozza",
year = "1988",
language = "English",
volume = "17",
pages = "417--418+425",
journal = "Dialysis and Transplantation",
issn = "0090-2934",
publisher = "John Wiley and Sons Inc.",
number = "8",

}

TY - JOUR

T1 - Diabetics in hemodialysis

T2 - Glycemic control by open-loop devices

AU - Spotti, D.

AU - Slaviero, G.

AU - La Rocca, E.

AU - Quartagno, R.

AU - Melandri, M.

AU - Pozza, G.

PY - 1988

Y1 - 1988

N2 - The blood-sugar level in insulin-dependent diabetic patients with end-stage renal disease (ESRD) during hemodialysis treatment is difficult to control. Use of an open-loop device for continuous subcutaneous insulin delivery is preferred in the treatment of uremic diabetics to obtain acceptable glycemic control. We reported our experience of achieving better metabolic control using the micropump instead of intensive conventional insulin administration in diabetic hemodialysis patients.

AB - The blood-sugar level in insulin-dependent diabetic patients with end-stage renal disease (ESRD) during hemodialysis treatment is difficult to control. Use of an open-loop device for continuous subcutaneous insulin delivery is preferred in the treatment of uremic diabetics to obtain acceptable glycemic control. We reported our experience of achieving better metabolic control using the micropump instead of intensive conventional insulin administration in diabetic hemodialysis patients.

UR - http://www.scopus.com/inward/record.url?scp=0023726201&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0023726201&partnerID=8YFLogxK

M3 - Article

AN - SCOPUS:0023726201

VL - 17

SP - 417-418+425

JO - Dialysis and Transplantation

JF - Dialysis and Transplantation

SN - 0090-2934

IS - 8

ER -